Research Library
Clinical ResearchFeatured

BPC-157 and Tissue Repair Signaling Pathways

Pentadecapeptide mechanisms in angiogenesis and mucosal healing.

Axis Research
6/26/2026
9 min read

Comprehensive review of BPC-157 mechanisms in tissue repair, angiogenesis, and mucosal healing.

BPC-157 and Tissue Repair Signaling Pathways

Overview

Body Protection Compound 157 (BPC-157), a synthetic pentadecapeptide derived from gastric juice, has been extensively studied for its role in tissue repair, angiogenesis, and mucosal barrier integrity.

Molecular Mechanisms

BPC-157 exerts pleiotropic effects through:

  • •Upregulation of vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF)
  • •Enhanced angiotensin-(1-7) signaling for vasodilation
  • •Nitric oxide-mediated endothelial function
  • •Modulation of growth hormone and IGF-1 pathways

Preclinical Evidence

Animal studies document BPC-157 efficacy in:

  • •Gastric ulcer healing (oral and topical)
  • •Muscle and tendon repair models
  • •Bone fracture consolidation
  • •Inflammatory bowel disease models
  • •Neurotrophic support in brain injury models

Research Significance

BPC-157 represents a robust research paradigm for understanding tissue-repair signaling and serves as an educational tool for regenerative medicine research.

Keywords

BPC-157tissue repairangiogenesisVEGFhealing

Referenced Compounds

(19)

Levothyroxine

Synthetic thyroxine (T4); thyroid hormone replacement

compound

Atorvastatin

HMG-CoA reductase inhibitor; lipid-lowering statin

compound

Spironolactone

Aldosterone receptor antagonist with antiandrogenic properties

compound

Warfarin

Vitamin K antagonist; oral anticoagulant with narrow therapeutic window

compound

Metformin

Biguanide AMPK activator; insulin sensitizer and metabolic regulator

compound

Dutasteride

Dual 5-alpha reductase inhibitor (types I and II)

compound

Finasteride

Type II 5-alpha reductase inhibitor; reduces DHT conversion

compound

Anastrozole

Nonsteroidal aromatase inhibitor; blocks estrogen biosynthesis

compound

Pinealon

Pineal-derived tripeptide targeting CNS neuroprotection, cognition, and circadian regulation

compound

Adalank

Adamantane-modified anxiolytic peptide with enhanced membrane permeability and prolonged half-life

compound

Pentadecapeptide

The BPC compound class studied for gastrointestinal cytoprotection and systemic healing.

compound

PE-22-28

Spadin-derived peptide blocking TREK-1 channels. Studied for neuroplasticity and mood research.

compound

Dihexa

An angiotensin IV analog studied for synaptogenesis via the HGF/MET signaling pathway.

compound

KPV

A tripeptide derived from alpha-MSH, studied for anti-inflammatory signaling via NF-κB inhibition.

compound

Adamax

N-Acetyl Semax Amidate — enhanced Semax derivative studied for cognitive enhancement and neuroplasticity.

compound

Selank

A synthetic heptapeptide derived from tuftsin, studied for GABAergic system influence and BDNF expression.

compound

TB-500

Synthetic fragment studied for actin regulation, cell migration, and tissue repair signaling.

compound

Semax

A synthetic ACTH fragment studied for neuroprotection and BDNF upregulation. Pharmaceutical approval in Russia for stroke recovery.

compound

BPC-157

FDA Cat. 1 Restored April 2026. A 15-amino-acid pentadecapeptide with 300+ preclinical papers.

compound
Research Use Only

For research use only. Not medical advice.

ARIA · Sign in to chat